# Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/anti-cancer-nanomedicines-a-revolution-of-tumor-immunotherapy/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Wei Li,Anghui Peng,Hua‐Jun Wu,Yingyao Quan,Yong Li,Ligong Lu,Min Cui |
| Citations | 29 |
| DOI | 10.3389/fimmu.2020.601497 |
| Fields | Engineering,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.frontiersin.org/articles/10.3389/fimmu.2020.601497/pdf |
| OpenAlex ID | https://openalex.org/W3118184329 |
| PMID | 33408716 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Min Cui](https://scholariq.org/researchers/min-cui/)

## Paper journal

- [Frontiers in Immunology](https://scholariq.org/journals/frontiers-in-immunology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Nanoplatforms for cancer theranostics](https://scholariq.org/topics/nanoplatforms-for-cancer-theranostics/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.